Alexandria Real Estate Equities has $183 million tied up in a North Tower it never built, and now its existing Manhattan leasehold could be on the chopping block as the developer battles New York City in court. The dispute has turned a once-promising life-sciences expansion into a fight over floodwalls, missed deadlines and who gets to control the city's next biotech hub.
At stake is the proposed third building at Alexandria Center for Life Science, the roughly $1.5 billion research campus near Bellevue Hospital and NYU Langone. The East and West towers were completed in 2010 and 2013, while the North Tower would add about 550,000 square feet and bring the campus to roughly 1.3 million square feet, according to Bisnow.
Alexandria's annual filing said its investment in the option parcel had reached $178.1 million by the end of 2025 and warned that potential losses could range from zero to the full investment, depending on whether the project can be developed or the money recovered. By June 30, the preconstruction tab had climbed to $183 million, with construction still not underway.
A Floodwall Dispute Turned Into A Lease Fight
The legal clash began with plans for a flood-protection system after Superstorm Sandy, which the city wanted integrated into the North Tower's foundation. Alexandria alleged that New York City Health + Hospitals and the New York City Economic Development Corp. changed or expanded the floodwall requirements, delaying the project and forcing the developer to absorb additional costs.
A March 27 ruling from the Southern District of New York dismissed Alexandria's fraudulent-inducement and implied-covenant claims, finding that the developer had not adequately shown the city made the alleged misrepresentations. The case was not entirely over: the court left Alexandria's request for a declaration that its option remains alive for a later factual determination, according to the March federal ruling.
New York City has separately argued that Alexandria failed to close on the option by November 3, 2024, and says the developer failed to provide sublease, tax and financial disclosures required under the ground lease. The city claims it can keep a $5 million security deposit, seeks at least $3.8 million in damages and sent a default notice in April; Alexandria responded with another lawsuit in May alleging a coordinated campaign to devalue and seize its leasehold, as detailed by Bisnow's report.
New York's Life-Science Bet Is Facing A Reality Check
The fight is unfolding against the backdrop of New York's ambitious push to build a life-sciences economy. The city launched LifeSciNYC in 2016 with a billion-dollar commitment, but the sector has since moved into a slower-growth phase as new construction, leasing demand and rents cool, according to a NYC Planning report and Cushman & Wakefield.
Meanwhile, the city continues backing competing facilities, including proposed life-sciences and medical-technology space at Brooklyn Navy Yard Building 303. New York also offered up to $2 million in tax credits for Radical AI's planned materials-science laboratories at the Navy Yard, a sign that the public-sector development race Alexandria says is hurting its campus is still very much alive.
What Happens To The Alexandria Campus Next
Alexandria's North Tower remains unbuilt, its $183 million investment remains exposed and the leasehold itself could be terminated if the alleged default is not cured. The dispute now hinges on whether the project can be revived through the remaining court fight—or whether the East Side campus becomes collateral damage from New York's biotech boom and its painful correction.
